The Journal of Neuroscience, August 27, 2003, 23(21):7917-7921
Previous Article | Next Article 
BRIEF COMMUNICATION
Secretory Vesicles Membrane Area Is Regulated in Tandem with Quantal Size in Chromaffin Cells
Liang-Wei Gong,1
Ismail Hafez,1
Guillermo Alvarez de Toledo,2 and
Manfred Lindau1
1School of Applied and Engineering Physics,
Cornell University, Ithaca, New York 14850, and
2Department of Physiology and Biophysics, Faculty of
Medicine, University of Seville, E-41009 Seville, Spain
 |
Abstract
|
|---|
The number of transmitter molecules released in a quantal event can be
regulated, and recent studies suggest that the modulation of quantal size is
associated with corresponding changes in vesicle volume
(Colliver et al., 2000
;
Pothos et al., 2002
). If so,
this could occur either by distension of the vesicle membrane or by
incorporation and removal of vesicle membrane. We performed simultaneous
measurements of vesicle membrane area and catecholamine release in individual
quantal events from chromaffin cells using cell-attached patch amperometry.
Cells were treated with reserpine, a vesicular monoamine transport blocker
that decreases quantal size, or L-dopa, a catecholamine precursor
that increases quantal size. We show that decrease and increase in quantal
size are associated with a respective decrease and increase in vesicle
membrane area. These results point to a novel mechanism of vesicle membrane
dynamics by which vesicles physically change their membrane area in response
to changes in transmitter content such that the intravesicular concentration
of transmitter is maintained.
Key words: quantal size; exocytosis; membrane dynamics; transmitter release; transmitter transport; patch amperometry
 |
Introduction
|
|---|
In most neurons, the postsynaptic response to released neurotransmitter
from single vesicles shows significant variations in amplitude
(Bekkers et al., 1990
;
Liu et al., 1999
). Such
variability may reflect presynaptic or postsynaptic mechanisms, or both
(Auger and Marty, 2000
).
Evidence has been presented that quantal response is limited by availability
of postsynaptic receptors (Tang et al.,
1994
; Auger and Marty,
1997
); however, other studies suggest that quantal variability is
caused by variations in the amount of transmitter released per synaptic
vesicle fusion event (Frerking et al.,
1995
; Liu et al.,
1999
). Various studies indicated that variability in quantal size
reflects the vesicle size distribution, whereas the transmitter concentration
inside the vesicles is constant (Van der
Kloot and Molgo, 1994
;
Finnegan et al., 1996
;
Albillos et al., 1997
;
Bruns et al., 2000
).
Manipulations affecting the loading of vesicles with transmitter modulate
quantal size (Sulzer and Pothos,
2000
). In the neuromuscular junction and midbrain dopamine
neurons, a marked increase in the amplitude of miniature excitatory
postsynaptic currents is induced by overexpression of vesicular
neurotransmitter transporters, suggesting that quantal size can be regulated
by changes in vesicular transporter activity
(Song et al., 1997
;
Pothos et al., 2000
). In
dopaminergic neurons and PC12 cells, the catecholamine precursor
L-dopa increases quantal size by enhancing formation of cytosolic
dopamine (Pothos et al., 1996
,
1998
), whereas the vesicular
monoamine transport inhibitor reserpine decreases quantal size
(Kozminski et al., 1998
;
Pothos et al., 1998
).
If the concentration within vesicles remains constant, this poses an
obvious problem for mechanisms that change quantal size by altering the number
of transmitter molecules within secretory vesicles. The volume of secretory
vesicles must change. Using amperometry and transmission electron microscopy,
it was suggested that the alterations of quantal size by L-dopa and
reserpine treatment were associated with swelling and shrinking of vesicles,
respectively (Colliver et al.,
2000
). In chromaffin cells, manipulations that enhance vesicular
pH gradients lead to an increase in both quantal size and vesicle volume,
whereas conditions that collapse vesicle pH gradients decrease quantal size
and vesicle volume (Pothos et al.,
2002
).
Swelling and shrinking of vesicles could occur by stretching and undulating
the membrane of the vesicle or through incorporation and loss of membrane.
Because the area of a cell membrane can be stretched by only
3%
(Evans et al., 1976
), the
former mechanism does not involve significant changes in membrane area,
whereas the latter mechanism does. Membrane capacitance measurements provide a
direct assay of changes in membrane area
(Neher and Marty, 1982
).
Cell-attached patch amperometry combines patch-clamp measurements of
capacitance steps, indicating vesicle membrane area
(Neher and Marty, 1982
), with
amperometric detection of released catecholamines by a carbon fiber electrode
(Wightman et al., 1991
;
Chow et al., 1992
) located
inside the patch pipette (Albillos et al.,
1997
). We used this method for simultaneous measurements of
vesicle membrane area and the amount of catecholamine secreted from the same
vesicle. We found that vesicle membrane area changes markedly in parallel with
changes in quantal size.
 |
Materials and Methods
|
|---|
Cells and recording configurations. Bovine chromaffin cells were
prepared and cultured as described
(Parsons et al., 1995
).
Cell-attached patch amperometry recordings were performed using the method
described previously (Albillos et al.,
1997
) on days 1-4 in culture. The patch pipette contained a carbon
fiber electrode and an Ag/AgCl reference electrode for amperometric detection
of catecholamines released into the pipette because of exocytosis in the
cell-attached patch. The sine wave for patch capacitance measurements was
applied to the bath. Changes of patch admittance were measured with a lock-in
amplifier (SR 830, Stanford Research Systems) using a 20 kHz, 50 mV (root mean
square) sine wave.
Whole-cell capacitance measurements were performed using cells with 15-17
µm diameter by adjustment of the C-slow capacitance compensation circuitry
of a HEKA EPC-8 amplifier using a 5 mV square pulse.
Reagents and solutions. The bath solution contained (in
mM): 140 NaCl, 5 KCl, 5 CaCl2, 1 MgCl2, 10
HEPES/NaOH, 10 glucose, pH 7.3. For cell-attached patch amperometry the
pipette solution contained (in mM): 50 NaCl, 100 TEA-Cl, 5 KCl, 10
CaCl2, 1 MgCl2, 10 HEPES/NaOH, pH 7.3. For whole-cell
capacitance measurements the pipette contained solution contained (in
mM): 140 K-glutamate, 8 NaCl, 1 MgCl2, 0.1 EGTA, 1
Mg-ATP, 0.3 Na2GTP, 15 HEPES/KOH, pH 7.30. Chromaffin cells were
treated with 100 µM L-dopa, 1 µM
reserpine, or (for controls) with the same amount of physiological saline or
dimethylsulfoxide (DMSO) in bath solution for 60 min at room temperature.
L-Dopa or reserpine was added from a 10 mM stock
solution in physiological saline or 1 mM in DMSO, respectively.
After treatment, the cells were transferred to bath solution without drug and
allowed 20 min to recover before recording. All recordings were completed
within 1-2 hr after the incubation period.
Data analysis. The number of catecholamine molecules in a vesicle
(quantal size) was determined by integrating the amperometric current of a
single event after baseline subtraction and dividing the resulting charge by
2e0 (e0 = elementary charge), assuming that two
electrons are transferred per molecule
(Baur et al., 1988
). The volume
of the individual vesicles was calculated using a specific capacitance of 9
fF/µm2 (Albillos et al.,
1997
) and assuming spherical geometry. To determine the average
vesicular concentrations, quantal size was plotted as a function of vesicle
volume for each vesicle, and a straight line through the origin was fitted to
the data points. The slope of the fit provides the average concentration and
the correlation coefficient provides an indication of the variability. Such
fits were performed for pooled data as well as for single cells as described
in Results.
 |
Results
|
|---|
To simultaneously measure quantal size and vesicle membrane area we
performed cell-attached patch amperometry capacitance measurements.
Capacitance steps associated with amperometric spikes
(Fig. 1) indicate exocytosis of
individual chromaffin granules. The membrane area of individual exocytosed
granules is proportional to the size of capacitance steps. The number of
catecholamine molecules in a vesicle is obtained by integrating the
amperometric current of the same vesicle after baseline subtraction
(Fig. 1) and dividing the
resulting charge by 2e0, assuming that two electrons are
transferred per molecule (Baur et al.,
1988
).

View larger version (13K):
[in this window]
[in a new window]
|
Figure 1. Patch amperometry recording showing detection of exocytosis of single
vesicle from bovine chromaffin cell. Simultaneous recording of membrane
capacitance (C), conductance (G), and amperometric current (A)
together with the running integral of the amperometric current (Q).
|
|
L-Dopa and reserpine change quantal size
In control cells, the average amperometric charge was 1.81 ± 0.14
pC, corresponding to 5.7 ± 0.4 x 106 molecules per
vesicle. As expected, incubation of the cells for 1 hr in the presence of 100
µM L-dopa increased the average quantal size by 70%
to 3.05 ± 0.26 pC or 9.4 ± 0.8 x 106 molecules
per vesicle. In contrast, a 1 hr treatment with 1 µM reserpine
decreased quantal size by 30% to 1.22 ± 0.1 pC or 3.8 ± 0.3
x 106 molecules per vesicle
(Fig. 2A). These mean
values were obtained from catecholamine-containing vesicles only. In addition,
some catecholamine-free vesicles are released, indicated by capacitance steps
that were not associated with an amperometric spike. The fraction of
catecholamine-free vesicles was 8% in control cells (12 of 153), 6% in
L-dopa-treated cells (8 of 129), and increased to 19% in
reserpine-treated cells (22 of 115), confirming previous observations in rat
chromaffin cells (Tabares et al.,
2001
).

View larger version (56K):
[in this window]
[in a new window]
|
Figure 2. Effects of L-dopa and reserpine on average quantal size
(A), capacitance step size (B), and vesicular volume
(C). Values are expressed as mean ± SEM. The number of quantal
events was 141 (from 30 cells) for control, 121 (from 27 cells) for
L-dopa, and 93 (from 23 cells) for reserpine. Significantly
different from control indicated as *p < 0.05 and
**p < 0.001 (t test). The vesicular
catecholamine concentrations (D) are the slopes of the straight lines
in Figure 3 A,
C,E.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Figure 3. Proportional relation between quantal size and vesicle volume for control
cells (A, B), L-dopa-treated cells (C, D), and
reserpine-treated cells (E, F). A, C, and E show
data points from all cells in a group; B, D, and F show data
points from individual cells only. Straight lines through the origin were
fitted to the data points. The slopes and correlation coefficients are
indicated on the panels.
|
|
L-Dopa and reserpine change vesicle membrane area
The average capacitance step size of catecholamine-containing vesicles in
control cells was 1.64 ± 0.08 fF. Interestingly, the average step size
was 41% higher in L-dopa-treated cells (2.31 ± 0.11 fF) and
16% lower in reserpine-treated cells (1.37 ± 0.08 fF)
(Fig. 2B). A
comparison between capacitance step size distributions and morphometric
analysis revealed a specific capacitance of 9 fF/µm2 for
granules of cultured bovine chromaffin cells
(Albillos et al., 1997
). The
average membrane area of exocytosed granules is thus 0.182 ± 0.009
µm2 in control cells, 0.257 ± 0.012 µm2 in
L-dopa-treated cells, and 0.152 ± 0.009 µm2 in
reserpine-treated cells. Thus, the changes in vesicle volumes associated with
changes in quantal size are caused by incorporation and removal of vesicle
membrane. The average step size of catecholamine-free vesicles was smaller
(0.60 ± 0.09 fF; n = 42), corresponding to an average vesicle
membrane area of 0.067 ± 0.01 µm2 for empty vesicles.
Vesicular catecholamine concentrations remain constant
The average vesicle volume in control cells was 8.2 ± 0.73 al.
L-Dopa increased the average volume by 62% to 13.3 ± 1.1 al,
and reserpine decreased the average volume by 24% to 6.2 ± 0.6 al
(Fig. 2C). Both
L-dopa and reserpine had no significant effects on vesicular
catecholamine concentrations (Fig.
2D), although they both significantly changed quantal
size and the vesicle membrane area.
Variability of vesicular concentrations is modulated by
L-dopa and reserpine
Figure 3A,C,E shows
proportional relationships between quantal size and vesicle volume for all
exocytotic events in each group as expected for constant vesicle
concentration. In control cells (Fig.
3A) the average vesicular concentration (slope) was 1.03
± 0.06 M, with a correlation coefficient of 0.78. The
variability in vesicular concentration is much smaller in individual cells
(Albillos et al., 1997
). The
fit for the single cell shown in Figure
3B gave a correlation coefficient of 0.92. Correlation
coefficients were determined for each cell with three or more events. The
median of correlation coefficients in individual cells was 0.92 for control
cells (n = 16 cells). Thus, most of the scatter in
Figure 3A comes from
cell-to-cell variability. L-Dopa-treated cells
(Fig. 3C) gave a
correlation coefficient of 0.90 in the ensemble and a median correlation
coefficient of 0.96 (n = 13 cells) in individual cells
(Fig. 3D). In
contrast, reserpine treatment (Fig.
3E) gave a much lower correlation coefficient (0.61) in
the ensemble. The increased scatter in vesicular concentrations is also seen
on the single cell level (Fig.
3F), with a median correlation coefficient of 0.63
(n = 8 cells). These results indicate a systematic change in
variability of vesicular concentrations on the single cell level.
 |
Discussion
|
|---|
Using cell-attached patch amperometry we have shown that the increase in
quantal size observed in cells treated with L-dopa and the decrease
in quantal size in cells treated with reserpine are accompanied by a
corresponding increase and decrease in capacitance step sizes under the
different conditions. The capacitance step size distribution in cultured
bovine chromaffin cells is in excellent agreement with morphometric analysis
of vesicle profiles in thin sections when a specific capacitance of 9
fF/µm2 is used to convert capacitance step size into vesicle
membrane area (Albillos et al.,
1997
). We thus interpret the increased capacitance step sizes in
L-dopa-treated cells and the decreased capacitance step sizes in
reserpine-treated cells as changes in vesicle membrane area.
Could there be an alternative explanation for the change in capacitance
step sizes in L-dopa and reserpine-treated cells? In principle, two
other phenomena could underlie this observation. One possibility would be that
in L-dopa-treated cells preferentially large vesicles are released
and that in reserpine-treated cells preferentially small vesicles are
released. This would mean that with these treatments neither vesicle membrane
area nor vesicle contents change but that these treatments instead would
selectively make small or large vesicles available for exocytosis. We consider
this possibility mechanistically very unlikely, and furthermore
reserpine-treated cells release increasing amounts of catecholamine-free
vesicles (Tabares et al.,
2001
), indicating that vesicular contents do change. In addition
to membrane area, vesicle capacitance depends on the value of the specific
capacitance (CS). Another possibility would thus be that
L-dopa and reserpine change CS. For example,
hydrophobic ions that incorporate into membranes can affect
CS of mast cell granules
(Oberhauser and Fernandez,
1995
); however, such treatments affect not only the capacitance of
the granules but also the capacitance of the plasma membrane
(Oberhauser and Fernandez,
1995
). We thus measured in the whole-cell configuration the plasma
membrane capacitance of chromaffin cells treated with L-dopa and of
control cells of similar size. The mean plasma membrane capacitance of
L-dopa-treated cells was 6.6 ± 0.15 pF (SEM; n = 9
cells) and was not significantly different from that of control cells (6.8
± 0.33 pF; SEM; n = 8 cells). Thus, L-dopa
treatment does not change CS, and the observed increase in
capacitance step sizes in L-dopa-treated cells reflects an increase
in vesicle membrane area.
The 41% increase in vesicle membrane area and associated volume increase
should be observable by electron microscopy. Indeed, such evidence has been
reported previously (Colliver et al.,
2000
). Both the ultrastructural studies combined with amperometric
recordings and our patch amperometry recordings lead to the same conclusion
that the change in quantal size is associated with a change in vesicle volume.
Our results provide a mechanistic explanation for the vesicle volume changes
and show that the physical vesicle membrane area is dynamic. Changes in
catecholamine content may lead to changes in osmotic pressure. The maximal
fractional area increase of biological membranes before lysis occurs is
2-4% (Evans et al., 1976
)
and cannot explain the observed 41% increase of vesicle membrane area that
occurs during incubation with L-dopa. The increase or decrease in
quantal size must thus be associated with a physical addition or removal of
parts of the vesicle membrane, respectively. Unusually large vesicles were
also observed in rat basophilic leukemia cells after prolonged incubation with
serotonin (Williams et al.,
1999
).
Changes in quantal size are not explained by compound exocytosis
One way to increase vesicle size would be via compound exocytosis, in which
vesicles would fuse inside the cell forming multivesicular compounds leading
to increased capacitance steps (Scepek and
Lindau, 1993
) and increased quantal size. If compound exocytosis
were the cause of increased vesicle membrane area and quantal size, we would
expect a proportional increase of quantal size and membrane area. In contrast,
a 43% increase of average vesicle membrane area is associated with a 70%
increase of average quantal size in L-dopa-treated cells. For
instance, the two largest events in Figure
3D represent vesicles with a membrane area of
0.46
µm2. If these were each formed by fusion of two vesicles with
area 0.23 µm2, then each of these smaller vesicles would have a
volume of 10 al and a quantal size of 12 amol. The compound would have a
quantal size of 24 amol and would deviate markedly from the straight line. In
contrast, the data points for the large vesicles are on the same straight
lines as the small ones (Fig.
3), with a quantal size of
33 amol. The observed proportional
relation between vesicle volume and quantal size is thus not consistent with
compound exocytosis as an explanation for events with large quantal size.
Vesicular membrane dynamics regulated by vesicle loading
The fact that reserpine decreases quantal size as well a vesicular membrane
area suggests that the modulation of vesicle size may occur by a different
mechanism. It appears that vesicle membrane can physically be added or
removed. The average step size of catecholamine-free vesicles was 0.6 fF,
significantly smaller than that of catecholamine-containing vesicles. A step
size of 0.6 fF converts to a vesicle diameter of
150 nm, which is very
close to the size of catecholamine-free vesicles in rat chromaffin cells
(Tabares et al., 2001
). It
thus appears that there is a lower size limit to which chromaffin vesicles can
be reduced. Over a wide range of concentrations, however, the vesicles can
regulate their size such that their catecholamine concentration remains fairly
constant after changes in vesicular catecholamine content. In
L-dopa-treated cells, transport into the vesicles and quantal size
are increased but there is no significant increase in vesicular concentration.
Interestingly, the variability of vesicular concentration is decreased under
these conditions, suggesting that the addition of vesicle membrane area is
tightly coupled to the increase in quantal size. When the uptake is inhibited
by reserpine, quantal size decreases as does vesicle membrane area, but the
vesicular concentrations become more variable. The mechanism decreasing
vesicular membrane area may thus be less tightly coupled to the decrease in
quantal size.
We conclude that although vesicular catecholamine concentrations may vary
from one cell to another (Albillos et al.,
1997
; Alés et al.,
1999
), chromaffin granules have a mechanism to add or remove parts
of their membrane area when catecholamine contents are increased or decreased.
This allows marked changes in average quantal size whereas the average
vesicular concentration is kept at a constant level. Our results clearly
indicate that membrane is selectively added to or subtracted from vesicles, in
contrast to volume changes caused by altered membrane tension or undulation.
The mechanism of vesicular membrane dynamics is presently unknown. The
increase and decrease in vesicle membrane area could be produced by a change
in osmotic pressure resulting from changes in vesicular content. A rapid
exoendocytosis cycle driven by pressure changes has been reported in plant
cell protoplasts (Zorec and Tester,
1993
; Homann and Thiel,
2002
) and may be a general mechanism of plasma membrane area
regulation in various cell types including neurons
(Morris and Homann, 2001
),
where increased osmotic pressure and membrane tension promote net exocytosis;
decreased osmotic pressure and membrane tension promote net endocytosis
(Dai et al., 1998
).
Alternatively, specific interactions of cargo molecules with low-affinity
receptors in the vesicle membrane may regulate vesicle membrane dynamics.
Previous electron microscopy studies of adrenal cell vesicles showed small
microvesicles present between the dense core and the vesicle membrane
(Ornberg et al., 1986
). These
intragranule microvesicles could contribute the material required to expand
chromaffin granule membranes when granules are loaded with increased amounts
of catecholamine; however, such intragranule vesicles were not reported in
other studies (Plattner et al.,
1997
; Koval et al.,
2001
).
Another possibility is that cytosolic phospholipid transport proteins
contribute to the changes in vesicle membrane area. An example is
phosphatidylinositol transfer protein, which plays a role in secretory vesicle
formation (Ohashi et al.,
1995
). Osmotically induced granule swelling and shrinking have
been studied by direct observation for the large secretory granules from beige
mouse mast cells (Brodwick et al.,
1992
). It was found that in disrupted cells, hypotonic swelling of
secretory granules was limited to 8% before the vesicle lysed. In contrast,
secretory vesicles in intact cells could swell by
50%
(Brodwick et al., 1992
). This
suggests that the source of the added vesicle membrane may be cytosolic.
In addition to phospholipid transport proteins, vesicle membrane could be
added by direct fusion or budding of small vesicles with chromaffin granules.
In L-dopa-loaded cells, the average capacitance step size increases
by 0.67 fF. Ultrastructural studies have shown that chromaffin cells contain
multiple types of vesicles (Koval et al.,
2001
). Small synaptic-like microvesicles (SLMVs) have a mean
diameter of 64 nm (Koval et al.,
2001
) corresponding to
0.12 fF per SLMV. Approximately five
or six such vesicles must fuse with a chromaffin granule to produce the
observed increase in membrane area; however, the number of such vesicles in
unstimulated cells is small (Koval et al.,
2001
). Chromaffin cells also contain small dense-core vesicles
(SDCGs) with a mean diameter of 72 nm corresponding to
0.15 fF per
vesicle that are more numerous (Koval et
al., 2001
). These vesicles were seen to bud from the Golgi and
also from large dense-core granules. SDCGs may thus represent the organelles
mediating chromaffin granule membrane dynamics regulated by transmitter
loading.
 |
Footnotes
|
|---|
Received July 2, 2003;
revised July 2, 2003;
accepted July 8, 2003.
This work was supported by National Institutes of Health Grant R01-NS38200,
the Nanobiotechnology Center (a National Science Foundation Science and
Technology Center, agreement No. ECS-9876771), and the Spanish Ministry of
Science and Technology. We thank Lori Kwan and Joan Lenz for the cell
preparation and excellent technical assistance, and Dr. David Sulzer for his
invaluable advice and comments on this manuscript.
Correspondence should be addressed to Dr. Manfred Lindau, School of Applied
and Engineering Physics, Cornell University, Ithaca, NY 14850. E-mail:
ml95{at}cornell.edu.
Copyright © 2003 Society for Neuroscience
0270-6474/03/237917-05$15.00/0
 |
References
|
|---|
Albillos A, Dernick G, Horstmann H, Almers W, Alvarez de Toledo G,
Lindau M (1997) The exocytotic event in chromaffin cells revealed
by patch amperometry. Nature 389:
509-512.[Medline]
Alés E, Tabares L, Poyato JM, Valero V, Lindau M, Alvarez de
Toledo G (1999) High calcium concentrations shift the mode of
exocytosis to the kiss-and-run mechanism. Nat Cell Biol
1: 40-44.[Medline]
Auger C, Marty A (1997) Heterogeneity of functional
synaptic parameters among single release sites. Neuron
19: 139-150.[Web of Science][Medline]
Auger C, Marty A (2000) Quantal currents at
single-site central synapses. J Physiol (Lond)
526: 3-11.[Abstract/Free Full Text]
Baur JE, Kristensen EW, May LJ, Wiedemann DJ, Wightman RJ
(1988) Fast-scan voltammetry of biogenic amines. Anal
Chem 60:
1268-1272.[Medline]
Bekkers JM, Richerson GB, Stevens CF (1990) Origin of
variability in quantal size in cultured hippocampal neurons and hippocampal
slices. Proc Natl Acad Sci USA 87:
5359-5362.[Abstract/Free Full Text]
Brodwick MS, Curran M, Edwards C (1992) Effects of
osmotic stress on mast cell vesicles of the beige mouse. J Membr
Biol 126:
159-169.[Web of Science][Medline]
Bruns D, Riedel D, Klingauf J, Jahn R (2000) Quantal
release of serotonin. Neuron 28:
205-220.[Web of Science][Medline]
Chow RH, Rüden LV, Neher E (1992) Delay in
vesicle fusion revealed by electrochemical monitoring of single secretory
events in adrenal chromaffin cells. Nature
356: 60-63.[Medline]
Colliver TL, Pyott SJ, Achalabun M, Ewing AG (2000)
VMAT-Mediated changes in quantal size and vesicular volume. J
Neurosci 20:
5276-5282.[Abstract/Free Full Text]
Dai J, Sheetz MP, Wan X, Morris CE (1998) Membrane
tension in swelling and shrinking molluscan neurons. J Neurosci
18: 6681-6692.[Abstract/Free Full Text]
Evans EA, Waugh R, Melnik L (1976) Elastic area
compressibility modulus of red cell membrane. Biophys J
16: 585-595.[Web of Science][Medline]
Finnegan JM, Pihel K, Cahil PS, Huang L, Zerby SE, Ewing AG,
Kennedy RT, Wightman RM (1996) Vesicular quantal size measured by
amperometry at chromaffin, mast, pheochromocytoma, and pancreatic
-cells. J Neurochem 66:
1914-1923.[Web of Science][Medline]
Frerking M, Borges S, Wilson M (1995) Variation in
GABA mini amplitude is the consequence of variation in transmitter
concentration. Neuron 15:
885-895.[Web of Science][Medline]
Homann U, Thiel G (2002) The number of K(+) channels
in the plasma membrane of guard cell protoplasts changes in parallel with the
surface area. Proc Natl Acad Sci USA 99:
10215-10220.[Abstract/Free Full Text]
Koval LM, Yavorskaya EN, Lukyanetz EA (2001) Electron
microscopic evidence for multiple types of secretory vesicles in bovine
chromaffin cells. Gen Comp Endocrinol
121: 261-277.[Web of Science][Medline]
Kozminski KD, Gutman DA, Davila V, Sulzer D, Ewing AG
(1998) Voltammetric and pharmacological characterization of
dopamine release from single exocytotic events at rat pheochromocytoma (PC12)
cells. Anal Chem 70:
3123-3130.[Medline]
Liu G, Choi S, Tsien RW (1999) Variability of
neurotransmitter concentration and nonsaturation of postsynaptic AMPA
receptors at synapses in hippocampal cultures and slices.
Neuron 22:
395-409.[Web of Science][Medline]
Morris CE, Homann U (2001) Cell surface area
regulation and membrane tension. J Membr Biol
179: 79-102.[Web of Science][Medline]
Neher E, Marty A (1982) Discrete changes of cell
membrane capacitance observed under conditions of enhanced secretion in bovine
adrenal chromaffin cells. Proc Natl Acad Sci USA
79: 6712-6716.[Abstract/Free Full Text]
Oberhauser AF, Fernandez JM (1995) Hydrophobic ions
amplify the capacitive currents used to measure exocytotic fusion.
Biophys J 69:
451-459.[Web of Science][Medline]
Ohashi M, Jan de Vries K, Frank R, Snoek G, Bankaitis V, Wirtz K,
Huttner WB (1995) A role for phosphatidylinositol transfer
protein in secretory vesicle formation. Nature
377: 544-547.[Medline]
Ornberg RL, Duong LT, Pollard HB (1986) Intragranular
vesicles: new organelles in the secretory granules of adrenal chromaffin
cells. Cell Tissue Res 245:
547-553.[Web of Science][Medline]
Parsons TD, Coorssen JR, Horstmann H, Almers W (1995)
Docked granules, the exocytic burst, and the need for ATP hydrolysis in
endocrine cells. Neuron 15:
1085-1096.[Web of Science][Medline]
Plattner H, Artalejo AR, Neher E (1997)
Ultrastructural organization of bovine chromaffin cell cortex-analysis by
cryofixation and morphometry of aspects pertinent to exocytosis. J Cell
Biol 139:
1709-1717.[Abstract/Free Full Text]
Pothos E, Desmond M, Sulzer D (1996)
L-3,4-dihydroxyphenylalanine increases the quantal size of
exocytotic dopamine release in vitro. J Neurochem
66: 629-636.[Web of Science][Medline]
Pothos EN, Davila V, Sulzer D (1998) Presynaptic
recording of quanta from midbrain dopamine neurons and modulation of the
quantal size. J Neurosci 18:
4106-4118.[Abstract/Free Full Text]
Pothos EN, Larsen KE, Krantz DE, Liu Y, Haycock JW, Setlik W,
Gershon MD, Edwards RH, Sulzer D (2000) Synaptic vesicle
transporter expression regulates vesicle phenotype and quantal size. J
Neurosci 20:
7297-7306.[Abstract/Free Full Text]
Pothos EN, Mosharov E, Liu KP, Setlik W, Haburcak M, Baldini G,
Gershon MD, Tamir H, Sulzer D (2002) Stimulation-dependent
regulation of the pH, volume and quantal size of bovine and rodent secretory
vesicles. J Physiol (Lond) 542:
453-476.[Abstract/Free Full Text]
Scepek S, Lindau M (1993) Focal exocytosis by
eosinophils: compound exocytosis and cumulative fusion. EMBO J
12: 1811-1817.[Web of Science][Medline]
Song H, Ming G, Fon E, Bellocchio E, Edwards RH, Poo M
(1997) Expression of a putative vesicular acetylcholine
transporter facilitates quantal transmitter packaging. Neuron
18: 815-826.[Web of Science][Medline]
Sulzer D, Pothos EN (2000) Regulation of quantal size
by presynaptic mechanisms. Rev Neurosci
11: 159-212.[Web of Science][Medline]
Tabares L, Ales E, Lindau M, Alvarez De Toledo G
(2001) Exocytosis of catecholamine-containing and
catecholamine-free granules in chromaffin cells. J Biol Chem
276: 39974-39979.[Abstract/Free Full Text]
Tang CM, Margulis M, Shi QY, Fielding A (1994)
Saturation of postsynaptic glutamate receptors after quantal release of
transmitter. Neuron 13:
1385-1393.[Web of Science][Medline]
Van der Kloot W, Molgo J (1994) Quantal acetylcholine
release at the vertebrate neuromuscular junction. Physiol Rev
74: 899-991.[Free Full Text]
Wightman RM, Jankowski JA, Kennedy RT, Kawagoe DT, Schroeder TJ,
Leszczyszyn DJ, Near JA, Diliberto Jr EJ, Viveros OH (1991)
Temporally resolved catecholamine spikes correspond to single vesicle release
from individual chromaffin cells. Proc Natl Acad Sci USA
88: 10754-10758.[Abstract/Free Full Text]
Williams RM, Shear JB, Zipfel WR, Maiti S, Webb WW
(1999) Mucosal mast cell secretion processes imaged using
three-photon microscopy of 5-hydroxytryptamine autofluorescence.
Biophys J 76:
1835-1846.[Web of Science][Medline]
Zorec R, Tester M (1993) Rapid pressure driven
exocytosis-endocytosis cycle in a single plant cell. Capacitance measurements
in aleurone protoplasts. FEBS Lett 333:
283-286.[Web of Science][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Lefkowitz, K. E. Fogarty, L. M. Lifshitz, K. D. Bellve, R. A. Tuft, R. ZhuGe, J. V. Walsh Jr., and V. De Crescenzo
Suppression of Ca2+ syntillas increases spontaneous exocytosis in mouse adrenal chromaffin cells
J. Gen. Physiol.,
September 28, 2009;
134(4):
267 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Tanis, J. J. Moresco, R. A. Lindquist, and M. R. Koelle
Regulation of Serotonin Biosynthesis by the G Proteins G{alpha}o and G{alpha}q Controls Serotonin Signaling in Caenorhabditis elegans
Genetics,
January 1, 2008;
178(1):
157 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Chiti and A. G. Teschemacher
Exocytosis of norepinephrine at axon varicosities and neuronal cell bodies in the rat brain
FASEB J,
August 1, 2007;
21(10):
2540 - 2550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Schwartz, T. Blackmer, T. Gerachshenko, and S. Alford
Presynaptic G-Protein-Coupled Receptors Regulate Synaptic Cleft Glutamate via Transient Vesicle Fusion
J. Neurosci.,
May 30, 2007;
27(22):
5857 - 5868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Grabner, S. D. Price, A. Lysakowski, A. L. Cahill, and A. P. Fox
Regulation of large dense-core vesicle volume and neurotransmitter content mediated by adaptor protein 3
PNAS,
June 27, 2006;
103(26):
10035 - 10040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.L. Muldoon, P.G. Tratnyek, P.M. Jacobs, N.D. Doolittle, G.A. Christoforidis, J.A. Frank, M. Lindau, P.R. Lockman, S.P. Manninger, Y. Qiang, et al.
Imaging and Nanomedicine for Diagnosis and Therapy in the Central Nervous System: Report of the Eleventh Annual Blood-Brain Barrier Disruption Consortium Meeting
AJNR Am. J. Neuroradiol.,
March 1, 2006;
27(3):
715 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Nagy, J. H. Kim, Z. P. Pang, U. Matti, J. Rettig, T. C. Sudhof, and J. B. Sorensen
Different Effects on Fast Exocytosis Induced by Synaptotagmin 1 and 2 Isoforms and Abundance But Not by Phosphorylation
J. Neurosci.,
January 11, 2006;
26(2):
632 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xu, K. S. Tang, V. B. Lu, C. P. Weerasinghe, A. Tse, and F. W. Tse
Maintenance of quantal size and immediately releasable granules in rat chromaffin cells by glucocorticoid
Am J Physiol Cell Physiol,
November 1, 2005;
289(5):
C1122 - C1133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. De Gois, M. K.-H. Schafer, N. Defamie, C. Chen, A. Ricci, E. Weihe, H. Varoqui, and J. D. Erickson
Homeostatic Scaling of Vesicular Glutamate and GABA Transporter Expression in Rat Neocortical Circuits
J. Neurosci.,
August 3, 2005;
25(31):
7121 - 7133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kim, C.-f. Zhang, Z. Sun, H. Wu, and Y. P. Loh
Chromogranin A Deficiency in Transgenic Mice Leads to Aberrant Chromaffin Granule Biogenesis
J. Neurosci.,
July 27, 2005;
25(30):
6958 - 6961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Daniels, C. A. Collins, M. V. Gelfand, J. Dant, E. S. Brooks, D. E. Krantz, and A. DiAntonio
Increased Expression of the Drosophila Vesicular Glutamate Transporter Leads to Excess Glutamate Release and a Compensatory Decrease in Quantal Content
J. Neurosci.,
November 17, 2004;
24(46):
10466 - 10474.
[Abstract]
[Full Text]
[PDF]
|
 |
|